Social Pulse: Threshold Pharmaceuticals Inc (THLD.OQ)
THLD.OQ on NASDAQ Stock Exchange Capital Market
5.30USD
1 Aug 2013
5.30USD
1 Aug 2013
Price Change (% chg)
$-0.12 (-2.21%)
$-0.12 (-2.21%)
Prev Close
$5.42
$5.42
Open
$5.48
$5.48
Day's High
$5.48
$5.48
Day's Low
$5.26
$5.26
Volume
125,670
125,670
Avg. Vol
127,854
127,854
52-wk High
$9.28
$9.28
52-wk Low
$3.95
$3.95
- Threshold Pharmaceuticals: A Stock With Lots Of Potential
- Rexahn's Oncology Platform Led By Its Akt-1 Inhibitor Challenges Big Pharma With Ground-Breaking Cancer Therapy
- New Pancreatic Cancer Drug an FDA Priority
- Investing In Cancer Research Is Worth The Risk: Echo He
- 3 Market Caps With Exceptionally High ROIC
- A Journey To Add Biotech To The Portfolio
Press Releases
- Threshold Pharmaceuticals Announces Presentation and Webcast at Oppenheimer 23rd Annual Healthcare Conference
- Threshold Pharmaceuticals Reports Updated Phase 2 Results Including Analyses of Maintenance Therapy With TH-302 Following Induction Therapy With TH-302 Plus Doxorubicin in Soft Tissue Sarcoma
- Threshold Pharmaceuticals Announces Presentation and Webcast at Lazard Capital Markets 9th Annual Healthcare Conference
- Threshold Pharmaceuticals Reports Third Quarter 2012 Financial and Operational Results
- Threshold Pharmaceuticals Announces Agreement With U.S. FDA on a Special Protocol Assessment for Planned Phase 3 Trial of TH-302 in Combination With Gemcitabine in Advanced Pancreatic Cancer

